Status: Recruiting
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.
Participants needed: 160
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Adneuris Therapeutics, Inc.Updated: Oct 13, 2026Locations: 15
Eligibility criteria
Adults 18 to 75 years of age. [+4]
Chronic pain condition that requires ongoing pain medication. [+7]